Effects of periprocedural atorvastatin therapy on patients undergoing percutaneous coronary intervention (PCI)

Trial Profile

Effects of periprocedural atorvastatin therapy on patients undergoing percutaneous coronary intervention (PCI)

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Sep 2015

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Angina pectoris; Coronary artery disease
  • Focus Pharmacodynamics
  • Acronyms ATTICA
  • Most Recent Events

    • 02 Sep 2015 Results (10-year Follow-up) presented at the ESC Congress 2015: Annual Congress of the European Society of Cardiology
    • 02 Jun 2011 Planned End Date changed to 16 Apr 2010.
    • 01 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top